<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB4154</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
    <script src="https://cdn.ilga.gov/assets/js/copy.js"></script>
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <div id="copyable-content">
            <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB4154 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB4154</pre></b></center><p> </p>Introduced 10/15/2025, by Rep. Natalie A. Manley<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>225 ILCS 85/7</code></td><td class="synopsis"><code>  </code><code>from Ch. 111, par. 4127</code></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Pharmacy Practice Act. Provides that the Department of </code><code>Financial and Professional Regulation shall authorize the examination of </code><code>applicants as pharmacists at such times and places as it may determine </code><code>(rather than not less than 3 times per year). Provides that the Department </code><code>and the Board of Pharmacy shall regularly monitor the North American </code><code>Pharmacist Licensure Examination or its successor to ensure that the </code><code>examination of applicants is of a character to give a fair test of the </code><code>qualifications of the applicant to practice pharmacy. Provides that </code><code>applicants for examination as pharmacists for the calendar years 2025, </code><code>2026, and 2027 shall be required to pass only the North American Pharmacist </code><code>Licensure Examination. Provides that the results from the Multistate </code><code>Pharmacy Jurisprudence Examination for such applicants shall be </code><code>disregarded and shall not prohibit an applicant who has successfully </code><code>passed the North American Pharmacist Licensure Examination from engaging </code><code>in the practice of pharmacy. Provides that applicants for examination as </code><code>pharmacists shall be required to pay, either to the Department or the </code><code>National Association of Boards of Pharmacy (rather than the designated </code><code>testing service), a fee covering the cost of providing the examination. </code><code>Provides that the Department shall notify applicants taking the </code><code>examination of their results no later than 2 weeks after (rather than </code><code>within 7 weeks of) the examination date. Makes conforming changes.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 15658 AAS 28830 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB4154</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 15658 AAS 28830 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning regulation.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Pharmacy Practice Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Section 7 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 85/7)</code><code>  </code><code>(from Ch. 111, par. 4127)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2028)</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 7. </code><code>Application; examination. </code><code>Applications for </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>original licenses shall be made to the Department in writing </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>or electronically on forms prescribed by the Department and </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>shall be accompanied by the required fee, which shall not be </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>refundable. Any such application shall require such </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>information as in the judgment of the Department will enable </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>the Board and Department to pass on the qualifications of the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>applicant for a license.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The Department shall authorize </code><u><code>the examination</code></u><code> </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><strike><code>examinations</code></strike><code> of applicants as pharmacists </code><strike><code>not less than 3 </code></strike></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><strike><code>times per year</code></strike><code> at such times and places as it may determine. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>The </code><u><code>North American Pharmacist Licensure Examination (NAPLEX) </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>or its successor shall be monitored regularly by the </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>Department and the Board of Pharmacy to ensure that the</code></u><code> </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>examination of applicants </code><u><code>is</code></u><code> </code><strike><code>shall be</code></strike><code> of a character to give a </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>fair test of the qualifications of the applicant to practice </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB4154</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 15658 AAS 28830 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>pharmacy.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>Applicants for examination as pharmacists for the calendar </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>years 2025, 2026, and 2027 shall be required to pass only the </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>North American Pharmacist Licensure Examination. The results </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>from the Multistate Pharmacy Jurisprudence Examination (MPJE) </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>for such applicants shall be disregarded and shall not </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>prohibit an applicant who has successfully passed the North </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>American Pharmacist Licensure Examination from engaging in the </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>practice of pharmacy.</code></u><code> </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Applicants for examination as pharmacists shall be </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>required to pay, either to the Department or the </code><u><code>National </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>Association of Boards of Pharmacy</code></u><code> </code><strike><code>designated testing service</code></strike><code>, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>a fee covering the cost of providing the examination. Failure </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>to appear for the examination on the scheduled date, at the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>time and place specified, after the applicant's application </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>for examination has been received and acknowledged by the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>Department or the </code><u><code>National Association of Boards of Pharmacy</code></u><code> </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><strike><code>designated testing service</code></strike><code>, shall result in the forfeiture of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>the examination fee. The examination shall be developed and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>provided by the National Association of Boards of Pharmacy.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>If an applicant neglects, fails</code><u><code>,</code></u><code> or refuses to take </code><u><code>the</code></u><code> </code><strike><code>an</code></strike><code> </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>examination or fails to pass </code><u><code>the</code></u><code> </code><strike><code>an</code></strike><code> examination for a license </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>under this Act within 3 years after filing his application, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>the application is denied. However, such applicant may </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>thereafter make a new application accompanied by the required </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>fee and show evidence of meeting the requirements in force at </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB4154</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 15658 AAS 28830 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>the time of the new application.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The Department shall notify applicants taking the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>examination of their results </code><u><code>no later than 2 weeks after</code></u><code> </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><strike><code>within 7 weeks of</code></strike><code> the examination date. Further, the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Department shall have the authority to immediately authorize </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>such applicants who successfully pass the examination to </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>engage in the practice of pharmacy.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>An applicant shall have one year from the date of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>notification of successful completion of the examination to </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>apply to the Department for a license. If an applicant fails to </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>make such application within one year</code><u><code>,</code></u><code> the applicant shall be </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>required to again take and pass the examination.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>An applicant who has graduated with a professional degree </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>from a school of pharmacy located outside of the United States </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>must do the following:</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) obtain a Foreign Pharmacy Graduate Examination </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>Committee (FPGEC) Certificate;</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) complete 1,200 hours of clinical training and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>experience, as defined by rule, in the United States or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>its territories; and</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) successfully complete the licensing requirements </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>set forth in Section 6 of this Act, as well as those </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>adopted by the Department by rule. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The Department may employ consultants for the purpose of </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>preparing and conducting examinations.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 100-497, eff. 9-8-17</code><code>.)</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
        </div>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>
    <script>
        enableWordFriendlyCopy({
          selector: '#copyable-content',
          baseUrl: 'https://ilga.gov/'
        });
    </script>
    

</body>
</html>
